| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.44 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |